1. Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA. Issue 2 (11th August 2020) Authors: Barata, Pedro; Agarwal, Neeraj; Nussenzveig, Roberto; Gerendash, Benjamin; Jaeger, Ellen; Hatton, Whitley; Ledet, Elisa; Lewis, Brian; Layton, Jodi; Babiker, Hani; Bryce, Alan; Garje, Rohan; Stein, Cy; Kiedrowski, Lesli; Saylor, Philip; Sartor, Oliver Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD42-01 PROPENSITY MATCHED COMPARISON OF RADICAL CYSTECTOMY WITH TRIMODALITY THERAPY FOR MUSCLE INVASIVE BLADDER CANCER (MIBC): A MULTI-INSTITUTIONAL STUDY. (May 2022) Authors: Zlotta, Alexandre R.; Ballas, Leslie K.; Niemierko, Andrzej; Lajkosz, Katherine; Kuk, Cynthia; Miranda, Gus; Drumm, Michael; Mari, Andrea; Thio, Ethan; Fleshner, Neil E.; Kulkarni, Girish S.; Chung, Peter; Bristow, Robert; Berlin, Alejandro; Sridhar, Srikala S.; Feldman, Adam S.; Wszolek, Matthew... Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗